Piper Sandler expressed continued confidence in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), maintaining an Overweight ...

Piper Sandler adjusted its outlook on Health Catalyst Inc. (NASDAQ:HCAT) shares, reducing the price target to $8 from the previous $12, while maintaining an Overweight rating on the stock. Currently ...

Piper Sandler provided a preview for the Security & Infrastructure Software (ETR:SOWGn) sector's January quarter, expressing optimism about the upcoming earnings reports. The firm's analysis ...

Piper Sandler adjusted its stance on Q32 Bio Inc. (NASDAQ: QTTB), downgrading the biotech firm's stock rating from Overweight to Neutral and significantly reducing the price target to $4.00 from the ...

SEATTLE, WA - WaFd Inc. (NASDAQ:WAFD), a $2.5 billion market cap company specializing in national commercial banking, announced today that its Board of Directors has declared a cash dividend for ...

In a challenging market environment, TNGX stock has reached a new 52-week low, with shares plummeting to $2.58. According to InvestingPro data, while the company maintains strong liquidity with a ...

Inc. (NIC (NASDAQ:EGOV)) has reached an impressive milestone, with its stock price hitting an all-time high of $118.35. This peak reflects a significant surge in investor confidence, as evidenced by ...

Deutsche Bank (ETR:DBKGn) initiated coverage on Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy rating and a price target of $12.00. The firm's analyst cited the significant drop in the company's ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Beyond Air (XAIR – Research Report) today and set a price target of $1.00. The ...

Piper Sandler analyst Alexander Goldfarb maintained a Hold rating on UDR (UDR – Research Report) today and set a price target of $48.00. The ...

Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education.